Exercise plus caloric restriction lowers soluble RAGE in adults with chronic kidney disease

The incidence of chronic kidney disease (CKD) has increased in recent years. CKD is associated with obesity, type 2 diabetes, and cardiovascular disease, although the mechanism remains unclear. Elevated soluble form of the receptor for advanced glycation end products ( RAGE) is related to proinflammatory signaling pathways that may promote diabetic nephropathy and vascular dysfunction. Because lifestyle modification reduces systematic inflammation in adults with obesity and hyperglycaemia, the hypothesis that exercise plus caloric restriction would lower soluble RAGE in adults with CKD was tested in this study.

[1]  H. Morgenstern,et al.  State-Level Awareness of Chronic Kidney Disease in the U.S. , 2017, American journal of preventive medicine.

[2]  D. Reda,et al.  Structured Exercise in Obese Diabetic Patients with Chronic Kidney Disease: A Randomized Controlled Trial , 2016, American Journal of Nephrology.

[3]  C. Martens,et al.  The Vascular Endothelium in Chronic Kidney Disease: A Novel Target for Aerobic Exercise , 2016, Exercise and sport sciences reviews.

[4]  S. Navaneethan,et al.  A Trial of Lifestyle Modification on Cardiopulmonary, Inflammatory, and Metabolic Effects among Obese with Chronic Kidney Disease , 2015, American Journal of Nephrology.

[5]  Hazel Huang,et al.  Exercise-induced lowering of fetuin-A may increase hepatic insulin sensitivity. , 2014, Medicine and science in sports and exercise.

[6]  G. Ogedegbe,et al.  Randomized Pilot Trial of Bariatric Surgery Versus Intensive Medical Weight Management on Diabetes Remission in Type 2 Diabetic Patients Who Do NOT Meet NIH Criteria for Surgery and the Role of Soluble RAGE as a Novel Biomarker of Success , 2014, Annals of surgery.

[7]  Eun Ji Lee,et al.  Receptor for Advanced Glycation Endproducts (RAGE), Its Ligands, and Soluble RAGE: Potential Biomarkers for Diagnosis and Therapeutic Targets for Human Renal Diseases , 2013, Genomics & informatics.

[8]  J. Kirwan,et al.  Pancreatic β-cell function increases in a linear dose-response manner following exercise training in adults with prediabetes. , 2013, American journal of physiology. Endocrinology and metabolism.

[9]  C. Flask,et al.  Fetuin-A is linked to improved glucose tolerance after short-term exercise training in nonalcoholic fatty liver disease. , 2013, Journal of applied physiology.

[10]  G. Schernthaner,et al.  The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity , 2012, International Journal of Obesity.

[11]  H. J. Yoo,et al.  Effects of exercise on sRAGE levels and cardiometabolic risk factors in patients with type 2 diabetes: a randomized controlled trial. , 2012, The Journal of clinical endocrinology and metabolism.

[12]  K. Kotani,et al.  Influence of Physical Activity Intervention on Circulating Soluble Receptor for Advanced Glycation end Products in Elderly Subjects , 2011, Journal of clinical medicine research.

[13]  C. Stump.  Physical Activity in the Prevention of Chronic Kidney Disease , 2011, Cardiorenal Medicine.

[14]  D. Panagiotakos,et al.  Renal function, cardiovascular disease risk factors' prevalence and 5-year disease incidence; the role of diet, exercise, lipids and inflammation markers: the ATTICA study. , 2010, QJM : monthly journal of the Association of Physicians.

[15]  F. Santilli,et al.  Soluble forms of RAGE in internal medicine , 2009, Internal and emergency medicine.

[16]  K. Kotani,et al.  Short-Term Low Calorie Diet Intervention Reduces Serum Advanced Glycation End Products in Healthy Overweight or Obese Adults , 2009, Annals of Nutrition and Metabolism.

[17]  T. Imaizumi,et al.  Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes. , 2008, Microvascular research.

[18]  B. Nicklas,et al.  Effects of exercise on adipokines and the metabolic syndrome , 2008, Current diabetes reports.

[19]  H. Tse,et al.  Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes , 2007, Diabetologia.

[20]  L. Blonde,et al.  Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients? , 2006, Expert review of cardiovascular therapy.

[21]  L. Leng,et al.  Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes , 2006, Diabetologia.

[22]  Ann Marie Schmidt,et al.  Advanced glycation end products: sparking the development of diabetic vascular injury. , 2006, Circulation.

[23]  V. Tesar,et al.  Soluble receptor for advanced glycation end products in patients with decreased renal function. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  S. Fukumoto,et al.  Plasma Level of Endogenous Secretory RAGE Is Associated With Components of the Metabolic Syndrome and Atherosclerosis , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[25]  S. Blair,et al.  Cardiorespiratory fitness and body mass index as predictors of cardiovascular disease mortality among men with diabetes. , 2005, Archives of internal medicine.

[26]  A. D'Angelo,et al.  Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension , 2005, Journal of hypertension.

[27]  Jing Chen,et al.  The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults , 2004, Annals of Internal Medicine.

[28]  T. Kislinger,et al.  RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E–Null Mice , 2002, Circulation.

[29]  K. Kawasaki,et al.  Roles of the AGE‐RAGE System in Vascular Injury in Diabetes a , 2000, Annals of the New York Academy of Sciences.

[30]  M. Matsuda,et al.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. , 1999, Diabetes care.

[31]  A. Schmidt,et al.  Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. , 1999, Circulation research.

[32]  S. Navaneethan,et al.  Lifestyle-induced decrease in fat mass improves adiponectin secretion in obese adults. , 2014, Medicine and science in sports and exercise.

[33]  P. Kuchynka,et al.  Levels of circulating biomarkers at rest and after exercise in coronary artery disease patients. , 2010, Physiological research.

[34]  R. K. Krishnan,et al.  Effects of exercise and caloric restriction on insulin resistance and cardiometabolic risk factors in older obese adults--a randomized clinical trial. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[35]  W. Ngah,et al.  Effect of Tai Chi exercise on DNA damage, antioxidant enzymes, and oxidative stress in middle-age adults. , 2009, Journal of physical activity & health.

[36]  T. Imaizumi,et al.  Advanced glycation end products (AGEs) and diabetic vascular complications. , 2005, Current diabetes reviews.

[37]  K. Gerbitz,et al.  Possible Significance of Advanced Glycation End Products in Serum in End-Stage Renal Disease and in Late Complications of Diabetes , 1996, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.